Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, placebo-controlled, multicentre phase 2/3 trial.

EBioMedicine·2022
Same author

Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum Disorder.

Neurology(R) neuroimmunology & neuroinflammation·2021
Same author

Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD.

Multiple sclerosis (Houndmills, Basingstoke, England)·2021
Same author

Ischemic Optic Neuropathy.

Continuum (Minneapolis, Minn.)·2019
Same author

Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders.

JAMA neurology·2018
Same author

High risk of postpartum relapses in neuromyelitis optica spectrum disorder.

Neurology·2017
Same journal

Concurrence of Inherited Nuclear and Mitochondrial DNA Optic Neuropathies.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2026
Same journal

Aspergillus-Infiltrated Optic Nerve Sheath Meningioma in Immunocompetent Host Mimicking Optic Neuritis.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2026
Same journal

Progression of Vitreous Detachment Leading to Exacerbation of Visual Field Loss in Acute Nonarteritic Anterior Ischemic Optic Neuropathy.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2026
Same journal

Characterizing the Role of Ophthalmologists in the Care of Patients With Suspected Giant Cell Arteritis at an Academic Medical Center.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2026
Same journal

Optic Disc Drusen Is Frequently Not Reported on Computed Tomography Scans Performed for Other Reasons.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2026
Same journal

Dorsal Midbrain Syndrome Due to Complicated Posterior Reversible Encephalopathy Syndrome.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2026
See all related articles

Related Experiment Video

Updated: May 22, 2026

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

Neuromyelitis optica.

Mark J Morrow1, Dean Wingerchuk

  • 1Department of Neurology, Harbor-UCLA Medical Center, Torrance, CA, USA. mmorrow@labiomed.org

Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society
|May 24, 2012
PubMed
Summary
This summary is machine-generated.

Neuromyelitis optica (NMO) is an inflammatory condition affecting the optic nerves and spinal cord. Early detection and targeted treatments are crucial for managing NMO and preventing severe disability.

More Related Videos

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

Related Experiment Videos

Last Updated: May 22, 2026

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

Area of Science:

  • Neurology
  • Immunology
  • Ophthalmology

Background:

  • Neuromyelitis optica (NMO) is a severe inflammatory demyelinating disease targeting optic nerves and spinal cord astrocytes.
  • It often presents initially as optic neuritis, mimicking multiple sclerosis, leading to diagnostic challenges.
  • The aquaporin-4 antibody (NMO-IgG) is a key biomarker, though current tests have limitations in sensitivity.

Purpose of the Study:

  • To highlight the importance of recognizing NMO in neuro-ophthalmology practice.
  • To discuss diagnostic criteria and challenges, particularly differentiating NMO from multiple sclerosis.
  • To review current and future therapeutic strategies for NMO management.

Main Methods:

  • Review of clinical presentations, diagnostic markers (NMO-IgG), and treatment protocols for NMO.
  • Analysis of patient cohorts presenting with optic neuritis and myelitis.
  • Evaluation of therapeutic responses to steroids, plasma exchange, and immunosuppressive agents.

Main Results:

  • Approximately 50% of NMO patients initially present with isolated optic neuritis.
  • High suspicion for NMO is warranted in specific clinical scenarios, including severe vision loss after optic neuritis or recurrent attacks.
  • Current preventative therapies involve B-lymphocyte suppression, based on limited evidence.

Conclusions:

  • NMO requires high clinical suspicion, especially in patients with optic neuritis and myelitis.
  • Accurate diagnosis is critical to guide appropriate treatment and improve patient outcomes.
  • Further research is needed for more sensitive diagnostic tools and targeted therapies for NMO.